Table 9.
Correlation of HDAC mRNA expression with progress free survival in different TP53 mutation status ovarian cancer patients.
| HDAC | TP53 mutation | cases | HR (95% CI) | P value |
|---|---|---|---|---|
| HDAC1 | yes | 483 | 0.86(0.68-1.08) | 0.1905 |
| no | 84 | 0.65(0.36-1.15) | 0.1316 | |
| HDAC2 | yes | 124 | 1.7(1.14-2.54) | 0.0087* |
| no | 19 | Not available | Not available | |
| HDAC4 | yes | 124 | 1.6(1.09-2.36) | 0.016* |
| no | 19 | Not available | Not available | |
| HDAC5 | yes | 124 | 1.59(1.07-2.37) | 0.0216* |
| no | 19 | Not available | Not available | |
| HDAC11 | yes | 124 | 2.16(1.44-3.26) | 0.0002* |
| no | 19 | Not available | Not available |
*: P<0.05